Last updated on January 2020

A Study of Daratumumab With the Addition of Recombinant Human Hyaluronidase (rHuPH20) for the Treatment of Participants With Relapsed or Refractory Multiple Myeloma


Find a site near you

Start Over

VU Medisch Centrum

Amsterdam, Netherlands
2.44miles
  Connect »